ADC THERAPEUTICS Trademark

Trademark Overview

On Thursday, November 5, 2020, a trademark application was filed for ADC THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the ADC THERAPEUTICS trademark a serial number of 90980910. The federal status of this trademark filing is REGISTERED as of Tuesday, April 16, 2024. This trademark is owned by ADC Therapeutics SA. The ADC THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations for use in the treatment of cancer and tumors; pharmaceutical preparations for use in the treatment of oncological diseases, disorders, and conditions; pharmaceutical preparations for human use, namely, pharmaceutical antibodies; pharmaceutical preparations for human use, namely, immunotherapies for the treatment of oncological diseases, disorders, and conditions; pharmaceutical preparations for the treatment of oncological diseases, disorders, and conditions; biological preparations for the treatment of oncological diseases, disorders, and conditions
adc therapeutics

General Information

Serial Number90980910
Word MarkADC THERAPEUTICS
Filing DateThursday, November 5, 2020
Status700 - REGISTERED
Status DateTuesday, April 16, 2024
Registration Number7360943
Registration DateTuesday, April 16, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 14, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for use in oncology; pharmaceutical preparations for use in the treatment of cancer and tumors; pharmaceutical preparations for use in the treatment of oncological diseases, disorders, and conditions; pharmaceutical preparations for human use, namely, pharmaceutical antibodies; pharmaceutical preparations for human use, namely, immunotherapies for the treatment of oncological diseases, disorders, and conditions; pharmaceutical preparations for the treatment of oncological diseases, disorders, and conditions; biological preparations for the treatment of oncological diseases, disorders, and conditions
NOT AVAILABLE"THERAPEUTICS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, January 6, 2021
Primary Code005
First Use Anywhere DateMonday, May 3, 2021
First Use In Commerce DateMonday, May 3, 2021

Trademark Owner History

Party NameADC Therapeutics SA
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressEpalinges, CH 1066
Party NameADC Therapeutics SA
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressEpalinges, CH 1066
Party NameADC Therapeutics SA
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressEpalinges, CH 1066

Trademark Events

Event DateEvent Description
Tuesday, April 13, 2021NON-FINAL ACTION WRITTEN
Monday, November 9, 2020NEW APPLICATION ENTERED
Wednesday, January 6, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 12, 2021ASSIGNED TO EXAMINER
Tuesday, April 13, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 13, 2021NON-FINAL ACTION E-MAILED
Tuesday, October 12, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, October 12, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 13, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 12, 2021NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, November 12, 2021FINAL REFUSAL E-MAILED
Friday, November 12, 2021FINAL REFUSAL WRITTEN
Wednesday, April 6, 2022TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, April 6, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 6, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 14, 2022PUBLISHED FOR OPPOSITION
Tuesday, April 26, 2022ASSIGNED TO EXAMINER
Tuesday, May 10, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 25, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 14, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 9, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, February 9, 2023SOU TEAS EXTENSION RECEIVED
Thursday, February 9, 2023SOU EXTENSION 1 FILED
Thursday, February 9, 2023SOU EXTENSION 1 GRANTED
Saturday, February 11, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 9, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, August 9, 2023SOU EXTENSION 2 FILED
Wednesday, August 9, 2023SOU EXTENSION 2 GRANTED
Friday, August 11, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 8, 2024TEAS STATEMENT OF USE RECEIVED
Thursday, February 8, 2024TEAS REQUEST TO DIVIDE RECEIVED
Monday, February 26, 2024DIVISIONAL REQUEST RECEIVED
Tuesday, February 27, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, March 8, 2024DIVISIONAL PROCESSING COMPLETE
Thursday, February 8, 2024USE AMENDMENT FILED
Thursday, March 14, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, March 8, 2024STATEMENT OF USE PROCESSING COMPLETE
Wednesday, March 13, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, April 16, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, April 16, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords

therapeutics pharmaceutical preparations treatment diseases conditions disorders oncological namely human immunotherapies